Drug Profile
CP 316311
Alternative Names: Corticotropin releasing factor antagonist - Pfizer; Corticotropin releasing hormone antagonist - PfizerLatest Information Update: 23 Aug 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antidepressants
- Mechanism of Action Corticotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders; Major depressive disorder
Most Recent Events
- 23 Aug 2006 Discontinued - Phase-II for Anxiety disorders in USA (unspecified route)
- 23 Aug 2006 Discontinued - Phase-II for Depression in USA (unspecified route)
- 05 Jan 2005 Phase-II clinical trials in Anxiety disorders in USA (unspecified route)